|

|
| Comprehensive
Program Development |
|
From product discovery through post
approval, CBR International Corp. provides comprehensive
services in program development for biologics, drugs and
medical devices. More than just “outside” consultants,
we prefer to work as integral members of your development
team, offering guidance on issues ranging from product development
and manufacture to preclinical and clinical testing, regulatory
approval, and post-approval protocols.
As your company contemplates clinical testing of a promising
new agent or device, the need for a comprehensive and organized
plan leading to regulatory submissions becomes apparent.
Our consultants can aid in the creation of in-depth tasks
and timelines to meet both your corporate objectives and
Agency requirements. As a member of your team, we can assist
in the creation of a clinical development plan that incorporates
the potential of your investigational product, opportunities
for accelerated approval, and a long-term marketing strategy.
We provide guidance on product-related issues such as quality
manufacturing for Active Pharmaceutical Ingredients and/or
final dosage forms, the development of specifications and
analytical methods, and the establishment of appropriate
stability programs.
The staff at CBR International will explore the requirements
for preclinical safety and toxicological testing, review
protocols, and suggest timelines that are appropriate for
your clinical development plan. We can also assist in the
design and outline of clinical trials, from Phase I safety
and tolerability studies through pivotal Phase III protocols.
CBR Consultants and affiliates have extensive experience
developing clinical programs, protocols and all study documents.
Furthermore, our staff has been extremely successful in
assisting companies with negotiating accelerated development
programs with the FDA.
CBR International has developed robust templates for all
areas of clinical, regulatory, manufacturing and quality
operations. We provide technical writing services for the
preparation of regulatory submissions, including Agency
meeting request letters, packages and applications. In addition,
our consultants can serve as the authorized regulatory representative
and FDA contact for your program. CBR International maintains
a broad network of expert contacts in all areas of product
development to meet your program’s needs.
Specific
Consulting and Development Experience
Consistent, thorough and up-to-date analysis of your evolving
needs is just the beginning of our commitment to your program.
For a comprehensive assessment of your program requirements,
please contact us by calling (720) 746-1190 or by email
at info@cbrintl.com.
Clinical Protocol
Development • Technical Writing • Informed Consent
• Clinical Trials Oversight • Technology Transfer
Documents • GAP Analysis • Clinical Trials Audits
• Case Report Form Development • Comparability
Protocols • Quality Systems Audits • Regulatory
Submissions • E-Documentation • SOP Writing
• Orphan Drug Applications • Export Request
Documentation • Meeting Requests • Regulatory
Documentation • IRB Support • Validation Protocol
Development
|
 |
|